RVL Pharmaceuticals plc (RVLPQ)
OTCMKTS: RVLPQ · Delayed Price · USD
0.0001
0.00 (0.00%)
Mar 25, 2024, 12:00 AM EDT - Market open

RVL Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016
Cash & Equivalents
44.5440.44114.0595.8770.8334.7419.56
Cash & Cash Equivalents
44.5440.44114.0595.8770.8334.7419.56
Cash Growth
10.14%-64.54%18.97%35.34%103.88%77.64%-
Receivables
3.032.133.1543.9156.4237.6443.76
Inventory
0.780.841.8321.3124.3816.9519.84
Other Current Assets
8.6215.9654.1211.5520.7225.511.05
Total Current Assets
56.9859.38173.15172.63172.36114.8394.21
Property, Plant & Equipment
1.792.234.3435.2231.2631.4127.73
Goodwill and Intangibles
69.7583.0690.94254.84591.25772.56854.11
Other Long-Term Assets
00102.510.560.750.942.45
Total Long-Term Assets
71.5485.29197.8290.63623.26804.91884.29
Total Assets
128.51144.67370.95463.26795.62919.74978.5
Accounts Payable
2.413.783.138.524.8736.0737.52
Current Debt
1.883.251.222.191.896.685.28
Other Current Liabilities
15.4413.0851.4465.2587.2481.9375.03
Total Current Liabilities
19.7220.1155.7875.94114124.68117.83
Long-Term Debt
55.6144.39220.4271.11266.94314.01323.74
Other Long-Term Liabilities
2.083.440.911.530.8445.2771.72
Total Long-Term Liabilities
57.6947.83221.31272.61297.78359.28395.46
Total Liabilities
77.4267.94277.09348.55411.78483.96513.3
Total Debt
57.4947.65221.62273.3268.83320.69329.02
Debt Growth
20.66%-78.50%-18.91%1.66%-16.17%-2.53%-
Retained Earnings
-569.22-517.53-452.61-373.02-102.120-
Comprehensive Income
01.7-2.23-2.23-1.85-0.630.27
Shareholders' Equity
51.0976.7393.86114.71383.85435.78465.21
Net Cash / Debt
-12.95-7.2-107.56-177.43-198-285.94-309.47
Net Cash Per Share
-0.14-0.11-1.77-3.39-4.37-6.67-309.42
Working Capital
37.2539.27117.3796.6958.36-9.85-23.62
Book Value Per Share
0.571.141.552.198.4810.17465.13
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).